bpc 157 and cholesterol Protecting Repairing the Body with BPC-157 Oral Liposomal BPC-157 • Peptides

The patient must receive the shots at the same time during each appointment

Clinical bottom line for GLP-1 agonists in PCOS Clearly benefits: Women with PCOS and insulin resistance and/or overweight/obesity specifically for improving cycle regularity, reducing hyperandrogenism, supporting sustained weight loss, and reducing long-term cardiometabolic risk

Tirzepatide is FDA-approved as Mounjaro for type 2 diabetes (2022) and as Zepbound for chronic weight management (2023) and for moderate-to-severe obstructive sleep apnea (2024), and it is EMA-approved as well

We work diligently to obtain and maintain third-party analytical reports (HPLC/LC-MS) and Certificates of Analysis for each batch, as part of our ongoing quality process